CU23582A1 - Péptidos con capacidad anti-tumoral e inmunomoduladora - Google Patents
Péptidos con capacidad anti-tumoral e inmunomoduladoraInfo
- Publication number
- CU23582A1 CU23582A1 CU20060047A CU20060047A CU23582A1 CU 23582 A1 CU23582 A1 CU 23582A1 CU 20060047 A CU20060047 A CU 20060047A CU 20060047 A CU20060047 A CU 20060047A CU 23582 A1 CU23582 A1 CU 23582A1
- Authority
- CU
- Cuba
- Prior art keywords
- peptides
- immunomodulatory
- lipopolysaccharide
- well
- effect
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 230000002519 immonomodulatory effect Effects 0.000 title abstract 4
- 230000000259 anti-tumor effect Effects 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 239000002158 endotoxin Substances 0.000 abstract 2
- 229920006008 lipopolysaccharide Polymers 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000001093 anti-cancer Effects 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000011443 conventional therapy Methods 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 210000005260 human cell Anatomy 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (16)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20060047A CU23582A1 (es) | 2006-02-24 | 2006-02-24 | Péptidos con capacidad anti-tumoral e inmunomoduladora |
| ARP070100749A AR059608A1 (es) | 2006-02-24 | 2007-02-22 | Peptidos con capacidad anti - tumoral e inmunomoduladora |
| MX2008010893A MX2008010893A (es) | 2006-02-24 | 2007-02-23 | Peptidos con capacidad anti-tumoral e inmunomoduladora. |
| RU2008137968/04A RU2430109C2 (ru) | 2006-02-24 | 2007-02-23 | Иммуномодулирующие и противоопухолевые пептиды |
| BRPI0708148A BRPI0708148B1 (pt) | 2006-02-24 | 2007-02-23 | peptídeos com capacidade antitumoral e imunomoduladora provenientes da região 32-51 da proteína lalf, compostos químicos miméticos aos peptídeos, composição farmacêutica e uso dos peptídeos e compostos químicos |
| JP2008555601A JP5069250B2 (ja) | 2006-02-24 | 2007-02-23 | 免疫調節及び抗腫瘍ペプチド |
| AT07711100T ATE493434T1 (de) | 2006-02-24 | 2007-02-23 | Immunmodulatorische und gegen tumore wirkende peptide |
| KR1020087023166A KR101456205B1 (ko) | 2006-02-24 | 2007-02-23 | 면역조절성 및 항-종양 펩티드 |
| US12/278,990 US8283324B2 (en) | 2006-02-24 | 2007-02-23 | Immunomodulatory and anti-tumour peptides |
| PCT/CU2007/000006 WO2007095867A1 (es) | 2006-02-24 | 2007-02-23 | Peptidos con capacidad anti-tumoral e inmunomoduladora |
| CA2638828A CA2638828C (en) | 2006-02-24 | 2007-02-23 | Immunomodulatory and anti-tumor peptides derived from lalf |
| AU2007218671A AU2007218671B2 (en) | 2006-02-24 | 2007-02-23 | Immunomodulatory and anti-tumour peptides |
| CN2007800138842A CN101426813B (zh) | 2006-02-24 | 2007-02-23 | 具有免疫调节和抗肿瘤能力的肽 |
| EP07711100A EP1992638B1 (en) | 2006-02-24 | 2007-02-23 | Immunomodulatory and anti-tumour peptides |
| ES07711100T ES2358845T3 (es) | 2006-02-24 | 2007-02-23 | Péptidos inmunomodulares y antitumorales. |
| ZA200807034A ZA200807034B (en) | 2006-02-24 | 2008-08-14 | Immunomodulatory and anti-tumour peptides |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20060047A CU23582A1 (es) | 2006-02-24 | 2006-02-24 | Péptidos con capacidad anti-tumoral e inmunomoduladora |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU23582A1 true CU23582A1 (es) | 2010-10-30 |
Family
ID=38123823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20060047A CU23582A1 (es) | 2006-02-24 | 2006-02-24 | Péptidos con capacidad anti-tumoral e inmunomoduladora |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8283324B2 (enExample) |
| EP (1) | EP1992638B1 (enExample) |
| JP (1) | JP5069250B2 (enExample) |
| KR (1) | KR101456205B1 (enExample) |
| CN (1) | CN101426813B (enExample) |
| AR (1) | AR059608A1 (enExample) |
| AT (1) | ATE493434T1 (enExample) |
| AU (1) | AU2007218671B2 (enExample) |
| BR (1) | BRPI0708148B1 (enExample) |
| CA (1) | CA2638828C (enExample) |
| CU (1) | CU23582A1 (enExample) |
| ES (1) | ES2358845T3 (enExample) |
| MX (1) | MX2008010893A (enExample) |
| RU (1) | RU2430109C2 (enExample) |
| WO (1) | WO2007095867A1 (enExample) |
| ZA (1) | ZA200807034B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU23674A1 (es) * | 2007-07-31 | 2011-05-27 | Ct Ingenieria Genetica Biotech | Péptidos penetradores a células fusionados a una biomolécula con acción terapéutica |
| EP2108372A1 (en) * | 2008-04-09 | 2009-10-14 | Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften | Novel antimicrobial peptides |
| US20120237535A1 (en) * | 2009-09-11 | 2012-09-20 | Proyecto De Biomedicina Cima, S.L. | Therapeutic Compositions For The Treatment of HPV-Induced Diseases |
| CU23897B1 (es) * | 2010-05-31 | 2013-05-31 | Ct De Ingeniería Genética Y Biotecnología | Péptido para la terapia del cáncer |
| CN103724412A (zh) * | 2013-09-29 | 2014-04-16 | 中国科学院海洋研究所 | 中国明对虾抗脂多糖因子及其制备和应用 |
| WO2024006746A1 (en) * | 2022-06-29 | 2024-01-04 | Cdres Pharma Llc | Immunologically active polypeptide |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2146667A1 (en) | 1993-08-18 | 1995-02-23 | Adolf Hoess | Lipopolysaccharide-binding and neutralizing peptides |
| CU22700A1 (es) | 1997-09-29 | 2001-07-31 | Ct Ingenieria Genetica Biotech | Formulación farmacéutica anti-viral que contiene un péptido de la proteína factor anti-lps de limulus y su uso |
| WO2002038164A1 (en) | 2000-11-08 | 2002-05-16 | Lorus Therapeutics Inc. | Combination preparation of a biological response modifier and an anticancer agent and uses thereof |
-
2006
- 2006-02-24 CU CU20060047A patent/CU23582A1/es unknown
-
2007
- 2007-02-22 AR ARP070100749A patent/AR059608A1/es not_active Application Discontinuation
- 2007-02-23 EP EP07711100A patent/EP1992638B1/en active Active
- 2007-02-23 RU RU2008137968/04A patent/RU2430109C2/ru not_active IP Right Cessation
- 2007-02-23 CA CA2638828A patent/CA2638828C/en not_active Expired - Fee Related
- 2007-02-23 AU AU2007218671A patent/AU2007218671B2/en not_active Ceased
- 2007-02-23 ES ES07711100T patent/ES2358845T3/es active Active
- 2007-02-23 CN CN2007800138842A patent/CN101426813B/zh not_active Expired - Fee Related
- 2007-02-23 US US12/278,990 patent/US8283324B2/en not_active Expired - Fee Related
- 2007-02-23 MX MX2008010893A patent/MX2008010893A/es active IP Right Grant
- 2007-02-23 AT AT07711100T patent/ATE493434T1/de not_active IP Right Cessation
- 2007-02-23 KR KR1020087023166A patent/KR101456205B1/ko not_active Expired - Fee Related
- 2007-02-23 WO PCT/CU2007/000006 patent/WO2007095867A1/es not_active Ceased
- 2007-02-23 BR BRPI0708148A patent/BRPI0708148B1/pt not_active IP Right Cessation
- 2007-02-23 JP JP2008555601A patent/JP5069250B2/ja not_active Expired - Fee Related
-
2008
- 2008-08-14 ZA ZA200807034A patent/ZA200807034B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200807034B (en) | 2009-06-24 |
| AR059608A1 (es) | 2008-04-16 |
| AU2007218671B2 (en) | 2012-02-09 |
| AU2007218671A1 (en) | 2007-08-30 |
| CA2638828A1 (en) | 2007-08-30 |
| CN101426813B (zh) | 2012-04-04 |
| RU2008137968A (ru) | 2010-03-27 |
| JP5069250B2 (ja) | 2012-11-07 |
| KR101456205B1 (ko) | 2014-10-31 |
| ATE493434T1 (de) | 2011-01-15 |
| US20090221508A1 (en) | 2009-09-03 |
| WO2007095867A1 (es) | 2007-08-30 |
| RU2430109C2 (ru) | 2011-09-27 |
| EP1992638A1 (en) | 2008-11-19 |
| CN101426813A (zh) | 2009-05-06 |
| CA2638828C (en) | 2014-09-09 |
| BRPI0708148A2 (pt) | 2011-05-17 |
| ES2358845T3 (es) | 2011-05-16 |
| JP2009527510A (ja) | 2009-07-30 |
| EP1992638B1 (en) | 2010-12-29 |
| US8283324B2 (en) | 2012-10-09 |
| KR20080106446A (ko) | 2008-12-05 |
| MX2008010893A (es) | 2008-09-03 |
| BRPI0708148B1 (pt) | 2019-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123010T1 (el) | Διεγερση γονιδιου τrail με μικρο μοριο απο κανονικα και ογκου κυτταρα ως αντικαρκινικη θεραπεια | |
| CY1121299T1 (el) | Υποκατεστημενες τρικυκλικες ενωσεις ως αναστολεις fgfr | |
| BR112012013664A2 (pt) | rabdovírus oncolítico | |
| CY1118714T1 (el) | Υψηλης συγγενειας ανθρωπινα αντισωματα κατα του ανθρωπινου ενεργοποιουμενου απο πρωτεαση υποδοχεα-2 | |
| DOP2015000110A (es) | Anticuerpos anti-ceacam5 y usos de estos | |
| CA2909432C (en) | Enhanced adoptive cell therapy | |
| CY1121742T1 (el) | Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων | |
| ECSP11011297A (es) | Proteinas ligadoras il-17 | |
| UY33850A (es) | Anticuerpos anti ? cd38 | |
| CY1114820T1 (el) | Νεες ανοσοενισχυτικες ενωσεις βασιζομενες σε φλαγκελλινη και χρηση αυτων | |
| MX2014003832A (es) | Molecula de union al antigeno que induce la inmunorespuesta al antigeno objetivo. | |
| EA201992712A3 (ru) | Трициклические гетероциклы как ингибиторы белков бэт | |
| CY1118859T1 (el) | 6-αλκινυλο-πυριδινες ως μιμητες smac | |
| MX2016016288A (es) | Polipeptidos efectores de la subunidad a de la toxina shiga resistentes a la disociacion por proteasa y moleculas dirigidas a las celulas que los comprenden. | |
| CR20110066A (es) | Anticuerpos monoclonales contra el factor tisular inhibidor de la via | |
| CO7180225A2 (es) | Tratamientos de combinación para melanoma que comprenden la administración de cobimetinib y vemurafenib | |
| CL2013000018A1 (es) | Compuestos derivados de indolizina , su procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer, entre otros. | |
| EA201290744A1 (ru) | Имидазо[1,2-b][1,2,4]триазины в качестве c-met ингибиторов | |
| EA201171435A1 (ru) | Твердые фармацевтические композиции и способы их получения | |
| CL2008001373A1 (es) | Compuestos derivados de fenilamino-benceno sustituidos; metodo de preparacion; composicion farmaceutica; kit farmceuticos; y uso de dichos compuestos en el tratamiento del cancer. | |
| EA201500261A1 (ru) | Конъюгаты антитело-лекарственное средство (adc), которые связываются с белками 158p1d7 | |
| ECSP12012134A (es) | Anticuerpos monoclonales optimizados contra el inhibidor de la vía del factor tisular (tfpi) | |
| CR20150604A (es) | Proceso para la preparación de eritrocitos cargados con una o más sustancias de interés farmacéutico y eritrocitos así obtenidos | |
| GT200900126A (es) | Novedosos anticuerpos antiproliferacion | |
| GT201500071A (es) | Antiandrògenos para el tratamiento del cancer de prostata residente a la castracion no metastàsico3 |